Showing results (61-70 of 105) with videos related to
Sort By:
Pageof 11
The Journal of Investigative Dermatology|May 4, 2012
Histology-specific microRNA alterations in melanomaLaura Poliseno, Adele Haimovic, Miguel F Segura, et al.Proceedings of the National Academy of Sciences of the United States of America|November 17, 2009
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survivalDusan Bogunovic, David W O'Neill, Ilana Belitskaya-Levy, et al.Journal of Translational Medicine|April 3, 2018
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitorsMichael F Gowen, Keith M Giles, Danny Simpson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanomaPatrick A Ott, Omid Hamid, Anna C Pavlick, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2019
Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant MelanomaAntoni Ribas, Adil Daud, Anna C Pavlick, et al.Plos One|January 6, 2011
A phase II trial of sorafenib in metastatic melanoma with tissue correlatesPatrick A Ott, Anne Hamilton, Christina Min, et al.Oncology|June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of CareChloe Goldman, Jeremy Tchack, Eric M Robinson, et al.Investigational New Drugs|November 12, 2017
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanomaSandra P D'Angelo, Omid A Hamid, Ahmad Tarhini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patientsBruce Ng, Jan Zakrzewski, Melanie Warycha, et al.Investigational New Drugs|August 7, 2012
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanomaPatrick A Ott, Richard D Carvajal, Neeta Pandit-Taskar, et al.Pageof 11